These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 24628915)
1. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study. De Geest S; Burkhalter H; Bogert L; Berben L; Glass TR; Denhaerynck K; ; Transpl Int; 2014 Jul; 27(7):657-66. PubMed ID: 24628915 [TBL] [Abstract][Full Text] [Related]
2. The role of goal cognitions, illness perceptions and treatment beliefs in self-reported adherence after kidney transplantation: a cohort study. Massey EK; Tielen M; Laging M; Beck DK; Khemai R; van Gelder T; Weimar W J Psychosom Res; 2013 Sep; 75(3):229-34. PubMed ID: 23972411 [TBL] [Abstract][Full Text] [Related]
3. Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions. Kung M; Koschwanez HE; Painter L; Honeyman V; Broadbent E Transplantation; 2012 May; 93(9):958-63. PubMed ID: 22343337 [TBL] [Abstract][Full Text] [Related]
4. Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients. Lieber SR; Helcer J; Leven E; Knight CS; Wlodarkiewicz C; Shenoy A; Shemesh E; Florman SS; Schiano TD; Annunziato RA Exp Clin Transplant; 2018 Oct; 16(5):533-540. PubMed ID: 28969524 [TBL] [Abstract][Full Text] [Related]
5. Patient-reported immunosuppression nonadherence 6 to 24 months after liver transplant: association with pretransplant psychosocial factors and perceptions of health status change. Rodrigue JR; Nelson DR; Hanto DW; Reed AI; Curry MP Prog Transplant; 2013 Dec; 23(4):319-28. PubMed ID: 24311395 [TBL] [Abstract][Full Text] [Related]
6. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Dobbels F; Vanhaecke J; Dupont L; Nevens F; Verleden G; Pirenne J; De Geest S Transplantation; 2009 May; 87(10):1497-504. PubMed ID: 19461486 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and correlates of self-reported pretransplant nonadherence with medication in heart, liver, and lung transplant candidates. Dobbels F; Vanhaecke J; Desmyttere A; Dupont L; Nevens F; De Geest S Transplantation; 2005 Jun; 79(11):1588-95. PubMed ID: 15940050 [TBL] [Abstract][Full Text] [Related]
8. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways. De Bleser L; Dobbels F; Berben L; Vanhaecke J; Verleden G; Nevens F; De Geest S Transpl Int; 2011 Sep; 24(9):882-91. PubMed ID: 21740471 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study. Helmy R; Scalso de Almeida S; Denhaerynck K; Berben L; Dobbels F; Russell CL; de Aguiar Roza B; De Geest S; Clin Ther; 2019 Jan; 41(1):130-136. PubMed ID: 30591285 [TBL] [Abstract][Full Text] [Related]
11. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial. Han A; Min SI; Ahn S; Min SK; Hong HJ; Han N; Kim YS; Ahn C; Ha J PLoS One; 2019; 14(11):e0224595. PubMed ID: 31689320 [TBL] [Abstract][Full Text] [Related]
12. Influence of intention to adhere, beliefs and satisfaction about medicines on adherence in solid organ transplant recipients. Hugon A; Roustit M; Lehmann A; Saint-Raymond C; Borrel E; Hilleret MN; Malvezzi P; Bedouch P; Pansu P; Allenet B Transplantation; 2014 Jul; 98(2):222-8. PubMed ID: 24926826 [TBL] [Abstract][Full Text] [Related]
13. Discrepancies between beliefs and behavior: a prospective study into immunosuppressive medication adherence after kidney transplantation. Massey EK; Tielen M; Laging M; Timman R; Beck DK; Khemai R; van Gelder T; Weimar W Transplantation; 2015 Feb; 99(2):375-80. PubMed ID: 25606787 [TBL] [Abstract][Full Text] [Related]
14. Factors predictive of medication nonadherence after renal transplantation: a French observational study. Couzi L; Moulin B; Morin MP; Albano L; Godin M; Barrou B; Alamartine E; Morelon E; Girardot-Seguin S; Mendes L; Misdrahi D; Cassuto E; Merville P Transplantation; 2013 Jan; 95(2):326-32. PubMed ID: 23149477 [TBL] [Abstract][Full Text] [Related]
15. Assessing medication adherence in solid-organ transplant recipients. Su GC; Greanya ED; Partovi N; Yoshida EM; Shapiro RJ; Levy RD Exp Clin Transplant; 2013 Dec; 11(6):475-81. PubMed ID: 24344939 [TBL] [Abstract][Full Text] [Related]
16. Preferential adherence to immunosuppressive over nonimmunosuppressive medications in kidney transplant recipients. Terebelo S; Markell M Transplant Proc; 2010 Nov; 42(9):3578-85. PubMed ID: 21094819 [TBL] [Abstract][Full Text] [Related]
17. Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients. Connelly J; Pilch N; Oliver M; Jordan C; Fleming J; Meadows H; Baliga P; Nadig S; Twombley K; Shatat I; Taber D Pediatr Transplant; 2015 Aug; 19(5):555-62. PubMed ID: 25917112 [TBL] [Abstract][Full Text] [Related]
18. Multilevel Correlates of Immunosuppressive Nonadherence in Kidney Transplant Patients: The Multicenter ADHERE BRAZIL Study. Sanders-Pinheiro H; Colugnati FAB; Denhaerynck K; Marsicano EO; Medina JOP; De Geest S; ; Transplantation; 2021 Jan; 105(1):255-266. PubMed ID: 32150041 [TBL] [Abstract][Full Text] [Related]
19. The prevalence, risk factors, and outcomes of medication trade-offs in kidney and liver transplant recipients: a pilot study. Serper M; Reese PP; Patzer RR; Levitsky J; Wolf MS Transpl Int; 2018 Aug; 31(8):870-879. PubMed ID: 29178601 [TBL] [Abstract][Full Text] [Related]
20. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients. Sankaranarayanan J; Collier D; Furasek A; Reardon T; Smith LM; McCartan M; Langnas AN Res Social Adm Pharm; 2012; 8(3):228-39. PubMed ID: 21856247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]